Deals
Activist Elliott Presses GSK on Progress at Investor Meeting
This article is for subscribers only.
One of the world’s toughest hedge fund bosses has once again questioned the performance of GlaxoSmithKline Plc and its under-fire chief executive officer, Emma Walmsley.
Gordon Singer, head of Elliott Investment Management’s London office, asked Glaxo Chairman Jonathan Symonds to explain what was holding back Glaxo’s value creation and stock during a meeting with top shareholders Thursday, according to a person on the call, who didn’t want to be identified because the event was private.